IPSC logo

IPSC
Century Therapeutics Inc

713
Mkt Cap
$412.33M
Volume
444,071.00
52W High
$3.04
52W Low
$0.435
PE Ratio
-21.94
IPSC Fundamentals
Price
$2.31
Prev Close
$2.29
Open
$2.30
50D MA
$2.32
Beta
1.58
Avg. Volume
1.12M
EPS (Annual)
-$0.1107
P/B
1.27
Rev/Employee
$1.4M
$11.76
Loading...
Loading...
News
all
press releases
Century Therapeutics (NASDAQ:IPSC) Downgraded to Sell Rating by Wall Street Zen
Wall Street Zen downgraded shares of Century Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
What is HC Wainwright's Estimate for IPSC Q1 Earnings?
Century Therapeutics, Inc. (NASDAQ:IPSC - Free Report) - Equities researchers at HC Wainwright issued their Q1 2026 EPS estimates for shares of Century Therapeutics in a research note issued on...
MarketBeat·9d ago
News Placeholder
Century Therapeutics, Inc. (NASDAQ:IPSC) Given Consensus Recommendation of "Hold" by Brokerages
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) has been given an average recommendation of "Hold" by the seven ratings firms that are presently covering the stock, Marketbeat.com reports...
MarketBeat·11d ago
News Placeholder
Century Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Up 19.3% in March
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) saw a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 10,289,543 shares, an increase of 19.3% from the March 15th total of 8,626,834 shares. Based on an average daily volume...
MarketBeat·14d ago
News Placeholder
Century Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Update
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) was the recipient of a significant increase in short interest in March. As of March 13th, there was short interest totaling 8,626,834...
MarketBeat·1mo ago
News Placeholder
Century Therapeutics, Inc. (NASDAQ:IPSC) Given Average Recommendation of "Moderate Buy" by Brokerages
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the eight brokerages that are currently covering the firm, Marketbeat...
MarketBeat·1mo ago
News Placeholder
Century Therapeutics (NASDAQ:IPSC) Insider Sells $25,693.80 in Stock
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) insider Gregory Russotti sold 10,076 shares of the business's stock in a transaction that occurred on Thursday, March 12th. The stock was...
MarketBeat·2mo ago
News Placeholder
Century Therapeutics (NASDAQ:IPSC) SVP Sells $17,959.65 in Stock
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) SVP Douglas Carr sold 7,043 shares of the company's stock in a transaction on Thursday, March 12th. The stock was sold at an average price...
MarketBeat·2mo ago
News Placeholder
Century Therapeutics, Inc. (NASDAQ:IPSC) Sees Large Growth in Short Interest
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) was the target of a large increase in short interest during the month of February. As of February 27th, there was short interest totaling...
MarketBeat·2mo ago
News Placeholder
Century Therapeutics (NASDAQ:IPSC) Announces Quarterly Earnings Results, Beats Estimates By $0.04 EPS
Century Therapeutics (NASDAQ:IPSC - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.25) earnings per share (EPS) for the quarter, topping the consensus...
MarketBeat·2mo ago
<
1
2
...
>

Latest IPSC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.